To combat globally high prices of insulin, the World Health Organisation (W.H.O) has announced an initiative to allow drug companies to produce biosimilar insulin products. This would be through a...
Black Swan Analysis Blog
WHO Aims To Introduce Cheaper Generic Insulin
On November 20, 2019,
Tags
News,
Population,
Events,
Epidemiology,
Medicine,
Collaboration,
RxPriceIndex
Repatha Has List Price Slashed Ahead Of Schedule
On November 14, 2019,
Tags
Pricing Strategies,
RxPriceIndex